Concord Biotech Limited IPO Date, Price, Review and Details
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelConcord Biotech Limited IPO
August 04, 2023 - August 08, 2023
Closed
Apply with Angel One
Apply with Zerodha
Pre-Apply with Upstox
Concord Biotech Limited IPO
Concord Biotech Limited was incorporated in 2000, Concord Biotech Limited is a research-focused pharmaceutical company that produces Active Pharmaceutical Ingredients (API) using fermentation and semi-synthetic methods, along with creating final medical formulations. They create bio-pharmaceutical APIs using fermentation and semi-synthetic techniques in areas like immunosuppressants, oncology, and anti-infectives. Additionally, they develop formulations used in critical care for immunosuppressants, nephrology, and anti-infective drugs. APIs are like the powerful ingredients in medicines that fight diseases. Formulations, on the other hand, are the actual drug products that patients take, like tablets, capsules, or injections.Company Promoters:
- Sudhir Vaid
- Ankur Vaid
Objects of this Issue:
- Achieve the benefits of listing the
Equity Shares on the Stock Exchanges.
- Carry out the Offer for Sale of up
to 20,925,652 Equity Shares by the Selling Shareholder.
Financial Information of the Company:
Amount in Million (Rs.)
As on 31 Mar 2023
As on 31 Mar 2022
As on 31 Mar 2021
Total Assets
15,139.84
13,127.95
11,825.46
Total Liabilities
2,239.83
2,095.72
1,831.73
Net Profit
2,400.84
1,749.29
2,348.87
Amount in Million (Rs.)
As on 31 Mar 2023
As on 31 Mar 2022
As on 31 Mar 2021
Total Assets
15,139.84
13,127.95
11,825.46
Total Liabilities
2,239.83
2,095.72
1,831.73
Net Profit
2,400.84
1,749.29
2,348.87
Concord Biotech Limited IPO Schedule
1. Bid or Offer Opens on: 04 August 2023
2. Bid or Offer Closes on: 08 August 2023
3. Finalization of BoA: 11 August 2023
4. Initiation of Refunds: 14 August 2023
5. Credit of share to Demat account: 17 August 2023
6. Listing Date: 18 August 2023
Company Contact Details:
Concord Biotech Limited IPO
1482-86, Trasad Road
Dholka, Ahmedabad – 382225
Gujarat, India
Phone: 079-6813 8700
Email: complianceofficer@concordbiotech.com
Website: https://www.concordbiotech.com/
Concord Biotech Limited IPO Registrar Details:
Link Intime India Private Limited
C 101, 247 Park
L.B.S Marg
Vikhroli (West), Mumbai 400 083
Maharashtra, India
Phone: +91 810 811 4949
Frequently Asked Question
Concord Biotech Limited IPO is going to open on 04 August 2023.
Concord Biotech Limited IPO shares will get listed at NSE and BSE.
Link Intime India Private Limited is the registrar of Concord Biotech Limited IPO.
Concord Biotech Limited IPO will get listed on August 18, 2022.
You will receive the allotted shares in your Demat account on August 17, 2023.
Price of 1 share of Concord Biotech Limited IPO is ₹705 - ₹741.
The meaning of "Concord Biotech Limited IPO" is the Grey Market Premium (GMP) for the initial public offering (IPO) of Concord Biotech Limited IPO on the current day.
You can apply for an IPO from any place by using the internet as it is an online process. You can apply for an IPO using 2 methods i.e., ASBA and UPI. ASBA facility is provided by your bank and UPI method is offered by your stock broker. You can invest in Concord Biotech Limited IPO by using any one of these methods at your convenience.
Pre-issue shareholdings of Concord Biotech Limited IPO promoters are 78.83%
If you do not get the allotment of Concord Biotech Limited IPO shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Market lot size of the Concord Biotech Limited IPO is 20 shares.
Concord Biotech Limited IPO will be closed on 08 August 2023.
Face value of equity shares of Concord Biotech Limited IPO is ₹1.
Post-issue shareholdings of concord biotech ltd ipo promoters are 64.03%.
Comments for Concord Biotech Limited IPO Date, Price, Review and Details
0 comments